vs
Side-by-side financial comparison of Ladder Capital Corp (LADR) and SBC Medical Group Holdings Inc (SBC). Click either name above to swap in a different company.
SBC Medical Group Holdings Inc is the larger business by last-quarter revenue ($39.6M vs $22.3M, roughly 1.8× Ladder Capital Corp). Ladder Capital Corp runs the higher net margin — 71.0% vs 35.9%, a 35.2% gap on every dollar of revenue. On growth, SBC Medical Group Holdings Inc posted the faster year-over-year revenue change (-10.9% vs -18.0%). Ladder Capital Corp produced more free cash flow last quarter ($78.7M vs $51.2M). Over the past eight quarters, SBC Medical Group Holdings Inc's revenue compounded faster (-15.0% CAGR vs -22.5%).
Ladder Capital Corp is a leading commercial real estate finance firm operating primarily across the United States. It originates and manages a diversified portfolio of senior secured commercial mortgage loans, mezzanine debt, commercial mortgage-backed securities, and direct real estate assets, serving property owners, operators and developers across major market segments.
SBC Medical Group Holdings Inc. is a leading Japan-headquartered healthcare provider primarily focused on aesthetic medicine, dermatology, and anti-aging wellness services. It operates an extensive network of clinics across Japan, catering to both domestic patients and international medical tourists, with core offerings including cosmetic surgery and non-invasive skincare treatments.
LADR vs SBC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $22.3M | $39.6M |
| Net Profit | $15.9M | $14.2M |
| Gross Margin | — | 73.1% |
| Operating Margin | 69.5% | 32.5% |
| Net Margin | 71.0% | 35.9% |
| Revenue YoY | -18.0% | -10.9% |
| Net Profit YoY | -49.4% | 117.2% |
| EPS (diluted) | $0.13 | $0.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $22.3M | $39.6M | ||
| Q3 25 | $27.8M | $43.4M | ||
| Q2 25 | $21.5M | $43.4M | ||
| Q1 25 | $20.3M | $47.3M | ||
| Q4 24 | $27.2M | $44.4M | ||
| Q3 24 | $38.4M | $53.1M | ||
| Q2 24 | $34.3M | $53.1M | ||
| Q1 24 | $37.1M | $54.8M |
| Q4 25 | $15.9M | $14.2M | ||
| Q3 25 | $19.2M | $12.8M | ||
| Q2 25 | $17.1M | $2.5M | ||
| Q1 25 | $11.6M | $21.5M | ||
| Q4 24 | $31.3M | $6.5M | ||
| Q3 24 | $27.6M | $2.8M | ||
| Q2 24 | $32.1M | $18.5M | ||
| Q1 24 | $16.4M | $18.8M |
| Q4 25 | — | 73.1% | ||
| Q3 25 | — | 70.6% | ||
| Q2 25 | — | 69.2% | ||
| Q1 25 | — | 79.7% | ||
| Q4 24 | — | 76.3% | ||
| Q3 24 | — | 81.5% | ||
| Q2 24 | — | 74.2% | ||
| Q1 24 | — | 72.1% |
| Q4 25 | 69.5% | 32.5% | ||
| Q3 25 | 72.4% | 36.6% | ||
| Q2 25 | 96.7% | 33.6% | ||
| Q1 25 | 52.7% | 51.1% | ||
| Q4 24 | — | 10.6% | ||
| Q3 24 | 74.1% | 26.1% | ||
| Q2 24 | 90.4% | 51.4% | ||
| Q1 24 | 49.4% | 44.6% |
| Q4 25 | 71.0% | 35.9% | ||
| Q3 25 | 69.0% | 29.6% | ||
| Q2 25 | 79.5% | 5.7% | ||
| Q1 25 | 56.8% | 45.4% | ||
| Q4 24 | 115.1% | 14.7% | ||
| Q3 24 | 71.7% | 5.3% | ||
| Q2 24 | 93.6% | 34.8% | ||
| Q1 24 | 44.2% | 34.2% |
| Q4 25 | $0.13 | $0.15 | ||
| Q3 25 | $0.15 | $0.12 | ||
| Q2 25 | $0.14 | $0.02 | ||
| Q1 25 | $0.09 | $0.21 | ||
| Q4 24 | $0.25 | $0.05 | ||
| Q3 24 | $0.22 | $0.03 | ||
| Q2 24 | $0.26 | $0.20 | ||
| Q1 24 | $0.13 | $0.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $38.0M | $164.1M |
| Total DebtLower is stronger | — | $42.8M |
| Stockholders' EquityBook value | $1.5B | $248.3M |
| Total Assets | $5.2B | $380.4M |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $38.0M | $164.1M | ||
| Q3 25 | $49.4M | $127.4M | ||
| Q2 25 | $134.9M | $152.7M | ||
| Q1 25 | $479.8M | $132.1M | ||
| Q4 24 | $1.3B | $125.0M | ||
| Q3 24 | $1.6B | $137.4M | ||
| Q2 24 | $1.2B | — | ||
| Q1 24 | $1.2B | — |
| Q4 25 | — | $42.8M | ||
| Q3 25 | — | $21.1M | ||
| Q2 25 | — | $7.1M | ||
| Q1 25 | — | $6.9M | ||
| Q4 24 | — | $6.6M | ||
| Q3 24 | — | $823.2K | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $1.5B | $248.3M | ||
| Q3 25 | $1.5B | $248.0M | ||
| Q2 25 | $1.5B | $244.6M | ||
| Q1 25 | $1.5B | $226.4M | ||
| Q4 24 | $1.5B | $195.1M | ||
| Q3 24 | $1.5B | $205.0M | ||
| Q2 24 | $1.5B | $8.8M | ||
| Q1 24 | $1.5B | $9.0M |
| Q4 25 | $5.2B | $380.4M | ||
| Q3 25 | $4.7B | $321.4M | ||
| Q2 25 | $4.5B | $315.3M | ||
| Q1 25 | $4.5B | $284.6M | ||
| Q4 24 | $4.8B | $266.1M | ||
| Q3 24 | $4.8B | $296.5M | ||
| Q2 24 | $4.8B | $19.5M | ||
| Q1 24 | $5.3B | $19.8M |
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.09× | ||
| Q2 25 | — | 0.03× | ||
| Q1 25 | — | 0.03× | ||
| Q4 24 | — | 0.03× | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $87.0M | $52.0M |
| Free Cash FlowOCF − Capex | $78.7M | $51.2M |
| FCF MarginFCF / Revenue | 352.4% | 129.3% |
| Capex IntensityCapex / Revenue | 37.4% | 2.0% |
| Cash ConversionOCF / Net Profit | 5.49× | 3.66× |
| TTM Free Cash FlowTrailing 4 quarters | $118.3M | $23.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $87.0M | $52.0M | ||
| Q3 25 | $26.3M | $-20.9M | ||
| Q2 25 | $44.0M | $-8.3M | ||
| Q1 25 | $-28.7M | $1.9M | ||
| Q4 24 | $133.9M | $-7.3M | ||
| Q3 24 | $169.0M | $5.0M | ||
| Q2 24 | $45.4M | $19.2M | ||
| Q1 24 | $-20.4M | $3.7M |
| Q4 25 | $78.7M | $51.2M | ||
| Q3 25 | $25.9M | $-20.9M | ||
| Q2 25 | $43.4M | $-8.6M | ||
| Q1 25 | $-29.6M | $1.7M | ||
| Q4 24 | $127.4M | $-7.9M | ||
| Q3 24 | $166.0M | $4.6M | ||
| Q2 24 | $44.9M | $18.3M | ||
| Q1 24 | $-21.7M | $3.0M |
| Q4 25 | 352.4% | 129.3% | ||
| Q3 25 | 93.1% | -48.3% | ||
| Q2 25 | 201.6% | -19.9% | ||
| Q1 25 | -145.6% | 3.5% | ||
| Q4 24 | 468.2% | -17.8% | ||
| Q3 24 | 432.1% | 8.7% | ||
| Q2 24 | 131.0% | 34.5% | ||
| Q1 24 | -58.6% | 5.4% |
| Q4 25 | 37.4% | 2.0% | ||
| Q3 25 | 1.7% | 0.1% | ||
| Q2 25 | 2.9% | 0.7% | ||
| Q1 25 | 4.3% | 0.5% | ||
| Q4 24 | 23.9% | 1.3% | ||
| Q3 24 | 7.8% | 0.8% | ||
| Q2 24 | 1.3% | 1.6% | ||
| Q1 24 | 3.7% | 1.3% |
| Q4 25 | 5.49× | 3.66× | ||
| Q3 25 | 1.37× | -1.63× | ||
| Q2 25 | 2.57× | -3.39× | ||
| Q1 25 | -2.49× | 0.09× | ||
| Q4 24 | 4.27× | -1.12× | ||
| Q3 24 | 6.13× | 1.77× | ||
| Q2 24 | 1.41× | 1.04× | ||
| Q1 24 | -1.24× | 0.20× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LADR
Segment breakdown not available.
SBC
| Franchising | $10.3M | 26% |
| Medical Corporation Shobikai | $8.1M | 21% |
| Medical Corporation Nasukai | $7.2M | 18% |
| Management Services | $6.3M | 16% |
| Rental Services | $4.3M | 11% |
| Medical Corporation Association Furinkai | $3.0M | 8% |
| Japan Medical And Beauty Inc | $656.5K | 2% |
